Skip to main content
. 2016 Mar;13(3):209–217. doi: 10.11909/j.issn.1671-5411.2016.03.007

Figure 2. Kaplan-Meier analysis of 1-year primary endpoint (all-cause death/re-infarction/severe bleeding) in PPIs versus no-PPIs groups within each P2Y12 receptor inhibitors (clopidogrel or ticagrelor).

Figure 2.

PPIs: proton pump inhibitiors.